Literature DB >> 2888842

Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analog.

J A Jackson1, H B Hahn, C E Oltorf, T M O'Dorisio, A I Vinik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2888842     DOI： 10.1016/s0022-3476(87)80118-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome.

Authors:  J M Hawdon; M P Ward Platt; W H Lamb; A Aynsley-Green
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

Review 2.  Clinical use of the long acting somatostatin analogue octreotide in pediatrics.

Authors:  M T Tauber; A G Harris; P Rochiccioli
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

Review 3.  Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.

Authors:  A G Harris
Journal:  Gut       Date:  1994       Impact factor: 23.059

Review 4.  Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.

Authors:  P E Battershill; S P Clissold
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

Review 5.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.